Herbert Gershberg, M.D., F.A.C.P.; Dobroslav Matiasevic, M.D.; Zenaida C. Javier, M.D.
This content is PDF only. Please click on the PDF icon to access.
Eighteen subjects with retarded growth were treated with human growth hormone (HGH) for up to 7 years. The group included 5 with idiopathic hypopituitarism, 1 with isolated growth hormone deficiency, 3 with achondroplasia and dyschondroplasia, 1 with vitamin D-resistant rickets, 1 with malabsorption resulting from massive resection of the small intestine, 1 with regional ileitis, 1 with gonadal dysgenesis, 2 with corticosteroid-induced dwarfism, 1 with Fanconi's anemia, 1 with glycogen-storage disease, and 1 with constitutional dwarfism.
Significant improvement in growth (at least twice the pretreatment rate) was most marked in the children with pituitary insufficiency and in the 2 children
Gershberg H, Matiasevic D, Javier ZC. Treatment and Metabolic Studies with Human Growth Hormone in Retarded Growth.. Ann Intern Med. ;64:1161. doi: 10.7326/0003-4819-64-5-1161_1
Download citation file:
Published: Ann Intern Med. 1966;64(5):1161.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use